Global Venturi Masks Market 2017-2021
About Venturi Masks
A venturi mask or an air-entrainment mask is a medical device that delivers a known oxygen concentration to patients on controlled oxygen therapy. It can deliver oxygen concentrations ranging from 24% to 80% with flow rates of 4-12 L/min. The major clinical applications of venturi masks include COPD and asthma. The other applications include respiratory distress syndrome, cystic fibrosis (CF), pneumonia, acute myocardial infarction, severe trauma, and neuromuscular diseases causing ventilatory failure.
Technavio’s analysts forecast the global venturi masks market to grow at a CAGR of 16.46% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global venturi masks market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Venturi Masks Market 2017-2021
Technavio recognizes the following companies as the key players in the global venturi masks market: BD, Besmed Health Business, Flexicare Medical, Smiths Medical, and Salter Labs.
Other Prominent Vendors in the market are: DEAS, For Care Enterprise, Intersurgical, Sure Care, and Tylenol Medical Instrument.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing focus on improved product designs. The increasing demand for advanced venturi masks from patients and huge competition from other players in the market made the vendors to focus on innovative designs and offerings. The manufacturers are putting continuous efforts for developing venturi masks with lighter weight, fewer/one-piece interfaces, several styles and sizes with additional comfort and efficiency to meet the patients' preferences.”
According to the report, one driver in the market is increasing prevalence of chronic respiratory disorders. The healthcare industry has witnessed a paradigm shift from hospital care to homecare over the last decade. This trend is especially evident among the older population and people with chronic diseases. Technological advances and improvement in healthcare services are influencing many people to access home-based medical care to improve patient outcome and reduce healthcare expenditure. The availability of venturi masks with improved designs that are easy to use, combining comfort and efficiency, is increasing patient's preference for homecare to reduce the burden of high cost and lengthy hospital stays.
Further, the report states that one challenge in the market is unfavorable reimbursement scenario. Declining reimbursement and unfavorable shifts in the payer mix significantly impact the treatment of chronic disease conditions. Chronic respiratory disorders such as COPD, asthma, and pneumonia require long-term oxygen therapy. The Medicare reimbursement for home-based oxygen therapy in the US is limited to 36 months due to Deficit Reduction Act of 2005 (DRA). It prevents oxygen providers to receive reimbursement coverage for costs related to treatment beyond 36 months.
BD, Besmed Health Business, Flexicare Medical, Smiths Medical, and Salter Labs, DEAS, For Care Enterprise, Intersurgical, Sure Care, and Tylenol Medical Instrument.